172 related articles for article (PubMed ID: 28914599)
1. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
Luo J; Johnston BS; Kitsch AE; Hippe DS; Korde LA; Javid S; Lee JM; Peacock S; Lehman CD; Partridge SC; Rahbar H
Radiology; 2017 Dec; 285(3):788-797. PubMed ID: 28914599
[TBL] [Abstract][Full Text] [Related]
2. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
3. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
[TBL] [Abstract][Full Text] [Related]
4. Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
Kim JJ; Kim JY; Kang HJ; Shin JK; Kang T; Lee SW; Bae YT
Radiology; 2017 Jul; 284(1):45-54. PubMed ID: 28253106
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
6. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
Hoque A; Lippman SM; Boiko IV; Atkinson EN; Sneige N; Sahin A; Weber DM; Risin S; Lagios MD; Schwarting R; Colburn WJ; Dhingra K; Follen M; Kelloff GJ; Boone CW; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):249-59. PubMed ID: 11303595
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
[TBL] [Abstract][Full Text] [Related]
8. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients.
Choi HK; Cho N; Moon WK; Im SA; Han W; Noh DY
Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498
[TBL] [Abstract][Full Text] [Related]
11. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
[TBL] [Abstract][Full Text] [Related]
12. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of Breast Magnetic Resonance Imaging Compared to Mammography in the Preoperative Detection and Measurement of Pure Ductal Carcinoma In Situ: A Retrospective Analysis.
Preibsch H; Beckmann J; Pawlowski J; Kloth C; Hahn M; Staebler A; Wietek BM; Nikolaou K; Wiesinger B
Acad Radiol; 2019 Jun; 26(6):760-765. PubMed ID: 30149976
[TBL] [Abstract][Full Text] [Related]
14. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
Rauch GM; Hobbs BP; Kuerer HM; Scoggins ME; Benveniste AP; Park YM; Caudle AS; Fox PS; Smith BD; Adrada BE; Krishnamurthy S; Yang WT
Ann Surg Oncol; 2016 Feb; 23(2):482-9. PubMed ID: 26416712
[TBL] [Abstract][Full Text] [Related]
15. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
Jansen SA; Newstead GM; Abe H; Shimauchi A; Schmidt RA; Karczmar GS
Radiology; 2007 Dec; 245(3):684-91. PubMed ID: 18024450
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
17. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Wong JS; Kaelin CM; Troyan SL; Gadd MA; Gelman R; Lester SC; Schnitt SJ; Sgroi DC; Silver BJ; Harris JR; Smith BL
J Clin Oncol; 2006 Mar; 24(7):1031-6. PubMed ID: 16461781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]